Product Images Duloxetine

DULoxetine is a delayed-release capsule containing 30mg of medication. The bottle contains 60 capsules and can be identified with NDC #: 70518-3287-00. It was manufactured by Ajanta Pharma Ltd. in Paithan, India with the source NDC: 27241-0098-10. Specific storage directions are provided, stating to keep it between 20-26°C (63-77°F), with permitted excursions to 15-30°C (59-86°F) [See USP]. The package insert contains instructions for use, and the medication must be kept away from children. It was repackaged by RemedyRepack Inc. in Indiana, PA. However, the expiration date and lot number are not available.*

This data appears to be a chart showing the number of patients who experienced a relapse during a study of a placebo group versus a group taking a medication called Duloxetine. The x-axis shows the time from randomization to relapse in days, and the y-axis shows the number of patients. The chart suggests that Duloxetine may be more effective at preventing relapse than the placebo, based on the lower number of patients experiencing relapse in the Duloxetine group compared to the placebo group at various time points.*

This text describes a medication called "Duloxetine" in doses of 60/120 mg once a day as a treatment for pain. The text also includes a graph showing the percentage improvement in pain from the baseline.*

The graph shows the proportion of patients who experienced relapse over time after randomization to either placebo or Duloxetine treatment in days. It appears that patients on Duloxetine had a lower proportion of relapses compared to those on placebo.*

The text contains a table displaying the percentage of patients improved for different doses of Duloxetine and Placebo. The table also includes information on the percentage improvement in pain from baseline.*

This appears to be a chart showing the percentage of patients who improved with different treatment options for pain. The chart compares the effectiveness of Dulozetine (at different dosages) and a Placabo. The percentage of patients who experienced improvement in pain from baseline is also displayed.*

This is a report on the use of Duloxetine at doses of 60/120mg once daily as a placebo. The text includes a numerical table with percent improvement in pain from baseline. The remaining text seems to be non-sensical and unclear.*

The text describes a clinical trial involving the use of a placebo and a once-daily dose of Duloxetine 60 mg for pain relief. The trial measured the percent improvement in pain from baseline using BOCF (Baseline Observation Carried Forward) method. However, there is some garbled text and symbols that are not understandable.*